Clinical Trials on Primary Healthcare in Russian Federation

Total 932 results

Biocad

Completed

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Hepatitis | Hepatitis C | Hepatitis C/ Human Immunodeficiency Virus Coinfection

Russian Federation
AB Science

Completed

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Ovarian Cancer

France, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Anemia | Chronic Kidney Disease | Chronic Renal Failure

Russian Federation
Bayer

Completed

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice (REVITALISE)

Erectile Dysfunction

Korea, Republic of, Saudi Arabia, Singapore, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, Israel, Kyrgyzstan
Allergan

Completed

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
Merck Sharp & Dohme LLC

Recruiting

Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)

Nosocomial Pneumonia

United States, Estonia, Greece, Spain, Ukraine, Chile, Russian Federation, Colombia, Mexico
Merck KGaA, Darmstadt, Germany

Completed

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Growth Hormone Deficiency | Turner Syndrome

Argentina, Australia, Austria, Canada, France, Germany, Italy, Norway, Russian Federation, Singapore, Spain, Sweden, United Kingdom
AbbVie (prior sponsor, Abbott)
Almedis

Completed

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

Secondary Hyperparathyroidism

Russian Federation
Abbott

Completed

Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis

Endometriosis

Russian Federation
Ipsen

Completed

Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

Internal Endometriosis

Russian Federation
AB Science

Completed

Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer

Italy, Russian Federation, India, Canada, France, Malaysia
Bayer

Completed

Mirena in Idiopathic Menorrhagia

Idiopathic Menorrhagia

Croatia, Saudi Arabia, Bulgaria, Jordan, Romania, Russian Federation, Turkey, United Arab Emirates, Kuwait, India, Pakistan, Serbia, Sri Lanka
Sanofi

Completed

Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology (Alfahydro)

Hydronephrosis | Neurogenic Bladder

Canada, Poland, Russian Federation, Turkey, Bulgaria, India, Malaysia, Serbia, Slovakia, Taiwan, Estonia, Singapore
AbbVie

Terminated

A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation (COPI)

HIV-1 Infection

Russian Federation
AstraZeneca

Completed

Non-Interventional Study PREVENT (PREVENT)

Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients

Russian Federation
Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
Novartis Pharmaceuticals

Completed

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma (RECORD-4)

Metastatic Renal Cell Carcinoma

China, Argentina, Brazil, Russian Federation, Bulgaria, United States
Biocad

Recruiting

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA) (FERMATA)

Cervical Cancer

Georgia, Russian Federation, China, Turkey
Pfizer

Terminated

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Pneumonia, Bacterial

Canada, United States, Argentina, Australia, Brazil, Chile, Colombia, Croatia, France, Hungary, Korea, Republic of, Latvia, Russian Federation, Taiwan
AbbVie (prior sponsor, Abbott)
Almedis

Completed

Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

Genital Endometriosis

Russian Federation
Kidney Cancer Research Bureau

Completed

Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors (FavorAx)

Carcinoma, Renal Cell | Clear Cell Renal Cell Carcinoma

Russian Federation
Materia Medica Holding

Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Cystitis Chronic | Cystitis Bacterial | Recurrence of Chronic Bacterial Cystitis

Russian Federation
Hoffmann-La Roche

Completed

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Renal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant Melanoma

Canada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
Aridis Pharmaceuticals, Inc.

Completed

Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 (AR-301-002)

Staphylococcus Aureus | Pneumonia, Ventilator-Associated | Infection, Bacterial | Lung Infection

Belarus, Belgium, Brazil, China, Estonia, France, Georgia, Israel, Latvia, Mexico, Russian Federation, South Africa, Spain, Turkey, Ukraine
Alexion

Completed

A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

France, United Kingdom, Norway, Russian Federation, Netherlands, United States
Bayer

Completed

Comparative Efficacy of Ovule vs Tablet

Vulvovaginal Candidiasis | Clotrimazole | Ovulen

Russian Federation, Germany
Abbott

Recruiting

Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines (IRIS)

Infertility

Kazakhstan, Russian Federation
Biocad

Completed

Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

Anemia | Chronic Kidney Disease | End Stage Renal Failure on Dialysis

Russian Federation
University of Copenhagen
Göteborg University; Halmstad County Hospital; Public Dental Health Care System... and other collaborators

Active, not recruiting

Effects of Partical Excavation in One Versus Two Procedures of Primary Deep Caries (PAPRICA) (PAPRICA)

Primary Dental Caries

Denmark, Lithuania, Russian Federation, Sweden
Mologen AG

Completed

Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma (IMPACT)

Advanced Colorectal Carcinoma

United Kingdom, Germany, Austria, Czech Republic, France, Russian Federation
Kedrion S.p.A.

Recruiting

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10) (KIDCARES10)

Primary Immunodeficiency Disease

Italy, United States, Portugal, Hungary, Russian Federation, Slovakia
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Centre de recherche du Centre hospitalier... and other collaborators

Recruiting

Antibiotic Prophylaxis Before Shock Wave Lithotripsy (APPEAL)

Nephrolithiasis | Ureteral Calculi | Ureteral Stones

Finland, Brazil, Canada, Indonesia, Iran, Islamic Republic of, Ireland, Russian Federation, Saudi Arabia, Switzerland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction

Impotence

Spain, Korea, Republic of, Sweden, Russian Federation
Eli Lilly and Company

Completed

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

Fallopian Tube Neoplasms | Ovarian Cancer | Peritoneal Neoplasm

Spain, Poland, Belgium, Russian Federation, Germany
Biotest
Syneos Health

Completed

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Primary Immunodeficiency Disease

United States, Germany, Hungary, Russian Federation, Spain
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Bayer

Completed

Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

Carcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)

Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
Paratek Pharmaceuticals Inc

Completed

IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis

Acute Pyelonephritis

Georgia, Latvia, Russian Federation, Ukraine
Accenture

Completed

Dose-finding Study in Platinum-Resistant Ovarian Cancer

Recurrent Platinum-resistant Ovarian Cancer

Australia, Russian Federation, United Kingdom
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Astellas Pharma Europe B.V.

Completed

An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

Advanced Prostate Carcinoma

Russian Federation
PriCara, Unit of Ortho-McNeil, Inc.

Completed

An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia

Pneumonia | Ventilator-Associated Pneumonia | Bacterial Pneumonia | Infections, Nosocomial

United States, Ukraine, Argentina, India, Russian Federation, Croatia, Canada, Chile, France
Octapharma

Completed

Study of Octanorm Subcutaneous IG in Patients With PID

Primary Immune Deficiency Disorder

United States, Canada, Czechia, Hungary, Poland, Russian Federation, Slovakia
AO GENERIUM

Completed

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation) (NAP)

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

United Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
AstraZeneca

Recruiting

A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation (OVARD)

Ovarian Cancer

Russian Federation
European Organisation for Research and Treatment...

Completed

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

Prostate Cancer

Netherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
ObsEva SA
Iqvia Pty Ltd; Cytel Inc.; Scope International AG; PhinC Development

Active, not recruiting

PoC Study of OBE022 in Threatened Preterm Labour (PROLONG)

Preterm Labor

Spain, Russian Federation, Vietnam, Czechia, Finland, Israel
Centocor Research & Development, Inc.

Completed

A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer

United States, United Kingdom, Belgium, Russian Federation
Sanofi

Completed

Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction (ALFACHIN)

Neurogenic Urinary Bladder

United States, France, Canada, Poland, Germany, Portugal, Spain, Turkey, Bulgaria, Estonia, India, Malaysia, Philippines, Russian Federation, Serbia, Singapore, Slovakia, Taiwan

Clinical Trials on Primary Healthcare in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations